Chunliang Cheng
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Androgen deprivation therapy, neoadjuvant androgen deprivation therapy, and adjuvant androgen deprivation therapy in patients with locally advanced prostate cancer: a multi-center real-world retrospective study.
Journal: World journal of urology
Published: May 17, 2023
ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts.
Journal: Frontiers in genetics
Published: January 20, 2023
Prediction of clinically significant prostate cancer using a novel 68Ga-PSMA PET-CT and multiparametric MRI-based model.
Journal: Translational andrology and urology
Published: January 15, 2023
S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8+ T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2023
A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study.
Journal: Frontiers in genetics
Published: September 18, 2022
Music therapy effect on anxiety reduction among patients with cancer: A meta-analysis.
Journal: Frontiers in psychology
Published: August 26, 2022
Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study.
Journal: Cell reports. Medicine
Published: February 28, 2022
Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis.
Journal: Frontiers in pharmacology
Published: May 09, 2021
RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
Journal: Frontiers in oncology
Published: December 15, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026